<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE nitf SYSTEM "http://www.nitf.org/IPTC/NITF/3.3/specification/dtd/nitf-3-3.dtd">
<nitf change.date="June 10, 2005" change.time="19:30" version="-//IPTC//DTD NITF 3.3//EN">
  <head>
    <title>Corrections</title>
    <meta content="COR014403" name="slug"/>
    <meta content="30" name="publication_day_of_month"/>
    <meta content="9" name="publication_month"/>
    <meta content="2000" name="publication_year"/>
    <meta content="Saturday" name="publication_day_of_week"/>
    <meta content="Metropolitan Desk" name="dsk"/>
    <meta content="2" name="print_page_number"/>
    <meta content="A" name="print_section"/>
    <meta content="4" name="print_column"/>
    <meta content="Corrections; New York and Region" name="online_sections"/>
    <docdata>
      <doc-id id-string="1234885"/>
      <doc.copyright holder="The New York Times" year="2000"/>
      <identified-content>
        <classifier class="indexing_service" type="descriptor">Correction Stories</classifier>
        <org class="indexing_service">Bristol-Myers Squibb Co</org>
        <classifier class="online_producer" type="types_of_material">Correction</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/New York and Region</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/Corrections</classifier>
      </identified-content>
    </docdata>
    <pubdata date.publication="20000930T000000" ex-ref="http://query.nytimes.com/gst/fullpage.html?res=9E00E7DA143DF933A0575AC0A9669C8B63" item-length="85" name="The New York Times" unit-of-measure="word"/>
  </head>
  <body>
    <body.head>
      <hedline>
        <hl1>Corrections</hl1>
      </hedline>
      <abstract>
        <p>Correction of Sept 29</p>
      </abstract>
    </body.head>
    <body.content>
      <block class="lead_paragraph">
        <p>An article in Business Day yesterday about plans by Bristol-Myers Squibb to sell some businesses and focus on prescription drugs referred incorrectly to an earnings projection made by Charles A. Heimbold Jr., the company's chairman, at a meeting with securities analysts and investors. He said the company's earnings per share would increase 14 percent this year, not 11 percent. The company expects earnings per share to increase 11 percent in 2001.</p>
      </block>
      <block class="full_text">
        <p>An article in Business Day yesterday about plans by Bristol-Myers Squibb to sell some businesses and focus on prescription drugs referred incorrectly to an earnings projection made by Charles A. Heimbold Jr., the company's chairman, at a meeting with securities analysts and investors. He said the company's earnings per share would increase 14 percent this year, not 11 percent. The company expects earnings per share to increase 11 percent in 2001.</p>
      </block>
    </body.content>
  </body>
</nitf>
